购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Anti-uPAR/PLAUR Antibody-PE (6L393)

Rating icon 还可以
Anti-uPAR/PLAUR Antibody-PE (6L393)
产品编号 TMAY-01335P
别名 URKR, U-PAR, UPAR, plasminogen activator, urokinase receptor, CD87

Anti-uPAR/PLAUR Antibody-PE (6L393) 是一种 PE-conjugated Mouse 抗体,靶向 uPAR/PLAUR。Anti-uPAR/PLAUR Antibody-PE (6L393) 可用于 FCM。

Anti-uPAR/PLAUR Antibody-PE (6L393)

Anti-uPAR/PLAUR Antibody-PE (6L393)

Rating icon 还可以
Anti-uPAR/PLAUR Antibody-PE (6L393)
产品编号 TMAY-01335P 别名 URKR, U-PAR, UPAR, plasminogen activator, urokinase receptor, CD87

Anti-uPAR/PLAUR Antibody-PE (6L393) 是一种 PE-conjugated Mouse 抗体,靶向 uPAR/PLAUR。Anti-uPAR/PLAUR Antibody-PE (6L393) 可用于 FCM。

规格价格库存数量
25 T
¥ 895
5日内发货
100 T
¥ 2,785
5日内发货
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
化合物带有盐酸盐离子、硫酸盐离子等是否和其本身有什么区别?盐形式和游离态有什么区别?
盐和非盐形式化合物的活性分子是一样的,在生物实验中起到的效果也一致,活性和使用方法都是一样的。只是由于呈盐不同,物理性质比如溶解度会有差异。建议您根据溶解、实验需求进行选择。
如何选择某个靶点的特异性或总的抑制剂?特异性和非特异性的区别是什么?
抑制剂按照特异性分为广谱 pan 和特异性 selective 两种。Pan 为某个靶点总的抑制剂,对所有亚型或整个家族的成员都有抑制作用。Selective 抑制剂针对某个蛋白激酶的某个亚型或家族中某个成员抑制率特别高或有特异性抑制作用。 一般评价一个抑制剂的抑制效率主要看 IC50 值,IC50 值越低,说明抑制剂效率越高。建议您根据以上几个特征进行综合选择,也可联系技术帮您推荐相关抑制剂。
查看更多
联系我们获取更多批次信息

产品介绍

生物活性
产品描述
Anti-uPAR/PLAUR Antibody-PE (6L393) is a PE-conjugated Mouse antibody targeting uPAR/PLAUR. Anti-uPAR/PLAUR Antibody-PE (6L393) can be used in FCM.
别名URKR, U-PAR, UPAR, plasminogen activator, urokinase receptor, CD87
Ig Type
Mouse IgG1
克隆号
6L393
交叉反应
Human
验证活性
Flow cytometric analysis of human UPAR(CD87) expression on human whole blood granulocytes. Human whole blood granulocytes were stained with PE-conjugated anti-Human UPAR(CD87). The histogram were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.
应用
推荐剂量
10 μl/Test, 0.1 mg/ml
抗体种类
Monoclonal
宿主来源Mouse
构建方式This product is a recombinant monoclonal antibody expressed from HEK293 cells. Then conjugated with PE under optimum conditions, the unreacted PE was removed.
纯化方式Protein A
性状Liquid
缓冲液PBS solution containing 0.5% BSA and 0.03%ProClin300
研究背景Urokinase plasminogen activator (uPA) and/or its receptor (uPAR) are essential for metastasis, and overexpression of these molecules is strongly correlated with poor prognosis in a variety of malignant tumours. uPAR and uPA levels in both resected tumor tissue and plasma are of independent prognostic significance for patient survival in several types of human cancer. This system has classically been thought to drive tumor progression by mediating directed extracellular proteolysis on the surface of migrating or invading cells, and intervening with this proteolysis by targeting uPAR has been proposed to represent a novel approach for inhibiting tumor progression. uPAR, also known as PLAUR or CD87, has been implicated in the growth, metastasis, and angiogenesis of several solid and hemotologic malignancies. uPAR is a highly glycosylated, 55-60kDa integral membrane protein linked to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor. It is part of a cell surface system that also consists of the serine protease uPA and several specific inhibitors (plasminogen activator inhibitors 1 and 2). Additionally, the analysis of CD87 (urokinase-type plasminogen activator receptor - uPAR) expression has a potential role in the diagnostic or prognostic work-up of several hematological malignancies, particularly acute leukemia and multiple myeloma.
偶联与修饰
偶联
PE
其他可选修饰符
Unconjugated/APC/FITC/HRP
可提供抗体种类
5
抗原信息
免疫原
Recombinant Protein: Human PLAUR / CD87 protein (TMPY-02141)
抗原种属
Human
研究领域
Serine Proteases and Regulators
存储&运输
储存方式Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight.
运输方式Shipping with blue ice.

计算器

  • 稀释 计算器

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Anti-uPAR/PLAUR Antibody-PE (6L393) | purchase Anti-uPAR/PLAUR Antibody-PE (6L393) | Anti-uPAR/PLAUR Antibody-PE (6L393) cost | order Anti-uPAR/PLAUR Antibody-PE (6L393)